Patent directory · USPTO A61K / A61P
Patents matching “arginine”
17 pharma patents match "arginine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 17 pharmaceutical patents matching "arginine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12414953
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 11725008
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 11524962
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)
granted -
US 11452775
Detection of arginine methylation of EGFR for prediction of resistance to therapy
granted -
US 11254683
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 11220524
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 11214574
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 11208416
Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
granted -
US 11078205
Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
granted -
US 11028083
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 10711007
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 10570140
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 10537635
Detection of arginine methylation of EGFR for prediction of resistance to therapy
granted -
US 10172911
Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules
granted -
US 7923535
Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
granted -
US 7541139
Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
granted -
US 6476037
L-arginine and phosphodiesterase (PDE) inhibitor synergism
expired